Tag: Testing
HaystackAnalytics earns NABL-accredited for clinical genomics
This milestone cements HaystackAnalytics’ position at the forefront of high-quality molecular diagnostic testing in India
CDSCO ensuring strict drug quality, withdrawal rules apply on non conforming...
In case of drug samples declared as Not of Standard Quality by the Drugs Testing laboratories under CDSCO, the respective manufacturing firms are asked for immediate recall and stop further distribution of the Not of standard quality drugs in the market
BioVoice eMagazine February 2025 | Issue 2 | Volume 6
The Cover Story analyzes the Genome India Project and its role in driving self reliance in genomics. Read interviews of Kishore Karumanchi, CEO of aciana. Expert Insights by Pooja Bhatia, Technology Transfer Expert; and Dr Bilal Thangal TM, Medical Lead, NURA. Special Stories on the growing trend of Gut Health testing and HMPV Cases in India.
WinZO and Tata Memorial Hospital invest to set-up India’s first gene...
Through WinZO’s ‘Play to Prevent Cancer’ initiative, the platform and its users contribute to India’s first genetic counseling and testing lab
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures...
The newly raised funds will be utilized to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell therapies
Redcliffe Labs launches MPOX testing to strengthen national preparedness
With several cases reported in Africa, Europe, and parts of Asia, the urgency of this threat necessitates early preparedness
FACE TO FACE: Partha Pratim Das Mahapatra, Founder & CEO, EzeRx
Partha Pratim Das Mahapatra, Founder and CEO of EzeRx, decodes the company's revolutionary product, EzeCheck, claimed to be the world's first non-invasive hemoglobin testing device
BioVoice eMagazine March & April 2024 | Issue 2 | Volume...
Cover story tracks the journey of MedGenome, the India’s leading genomics solutions company. Startup Special features MyHealthcare App; Expert Insights by Dr Kausik Maiti, Parexel India; Ankit Kumar, Skye Air; Dr Sat Kumar Tomer, Satyukt Analytics; and Ritwik Bahuguna, Farlense Group
10,000 genome sequencing is a watershed moment for India: Dr Jitendra...
Announcing the GenomeIndia Flagship Programme of 10,000 Genome Sequencing in New Delhi, Dr Jitendra Singh said, India's bio-economy has grown 13 folds in the last 10 years from $10 billion in 2014 to over $130 billion in 2024
Next-generation sequencers market will reach $5.1 billion in 2033, forecasts GlobalData
With decreased test fees, GlobalData anticipates that the demand for routine diagnostic procedures, including cancer panel testing and non-invasive prenatal testing, will grow






























































